Science director: Nico Callewaert
Research at the VIB-UGent Center for Medical Biotechnology pushes the boundaries of biomolecular / bioinformatics research and engineering technologies.
The Center translates its novel technologies and insights to widely applicable research tools, vaccines, diagnostics and pharmaceuticals.
The Center educates and trains the next generation of medical biotechnology researchers and informs the public on the impact of biotechnology on human health.
MBC’s focus is to develop new and innovative molecular tools and technologies to challenge human health problems. An emerging and fascinating research theme at MBC is the development and production of new biopharmaceuticals and vaccines (movie). MBC is currently working on new applications in tuberculosis research, cancer treatment, antiviral immunity and others.
Nico Callewaert explains his strategy
VIB-UGent Center for Medical Biotechnology
Scientists & research:
- Nico Callewaert Lab
glycoconjugates - biological systems engineering - glycan profiling - post-translational modifications - glycomics
- Proteomics Expertise Lab
mass spectrometry-based protein technologies
- Sven Eyckerman Lab
interactomics, protein complexes, signal transduction
- Kris Gevaert Lab
COFRADIC - gel-free proteomics - bioinformatics - protein processing - protein modification
- Lennart Martens Lab
computational - proteomics - degradomics - interactomics - systems biology
- Xavier Saelens Lab
influenza - viral growth and purification - recombinant vaccines - oligomerization - antiviral immunity
- Jan Tavernier Lab
signal transduction - protein interactions - leptin - cytokine receptors - innate immune responses
Click here for an overview of the supporting staff